Navigation Links
What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study
Date:9/13/2008

BOSTON, Sept. 13 /PRNewswire-USNewswire/ -- Cardiovascular disease kills more women each year than all cancers combined. Although this statistic is gaining more recognition among physicians and patients, the unique risk factors and symptoms of female patients make diagnosis and prognosis of women with heart disease particularly challenging.

Data from the WOMEN Study: What is the Optimal Method of Ischemia Evaluation in WomeN presented today at the American Society of Nuclear Cardiology Annual Scientific Session seeks to compare exercise stress testing alone or with myocardial perfusion imaging to determine the best method for detecting heart disease in symptomatic women. The study goal is to determine the best method based upon a 2 year follow-up. Researchers will present baseline data from the study, including demographics, pre-test likelihood of coronary artery disease, and initial test results.

"The strength of this study is the large enrollment and careful follow-up to optimize diagnostic strategies in symptomatic women," said Dr. Gary Heller, who will be presenting data at today's meeting on behalf of the four investigators who initiated the study -- Drs. Gary Heller, Robert Hendel, Jennifer Mieres, and Leslee Shaw. "The goal of the study is to improve outcomes in women with coronary artery disease by earlier and better detection."

During a two-year recruitment period, 826 patients were enrolled from 46 sites. Entry criteria were based on American College of Cardiology guidelines and the ability to exercise as determined by the Duke Activity Status (DASI) questionnaire. Women were randomized to either electrocardiogram exercise tolerance testing (ETT) alone or ETT with Tc-99m tetrofosmin SPECT myocardial perfusion imaging. Ongoing results are monitored by a Data Safety and Monitoring Board with all events adjudicated. Major adverse cardiac events will be evaluated at one and two years.

Dr. Gary Heller will present this study, "What Is the Optimal Method for Ischemia Evaluation in Women: Preliminary Data from the WOMENs Trial" Saturday, September 13, 2008 at 10:50 a.m. in Room 306.

The American Society of Nuclear Cardiology (ASNC) is the leader in education, advocacy, and quality for the field of nuclear cardiology. Serving more than 5,000 individuals in over 50 countries, ASNC is the only professional association dedicated to the dynamic subspecialty of nuclear cardiology.


'/>"/>
SOURCE American Society of Nuclear Cardiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Genetics Determine Optimal Drug Dose of Common Anticoagulant
2. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
5. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
6. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
7. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
8. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
9. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
10. febit and TGen Collaborate to Study New DNA Capture Method
11. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  CVS Pharmacy, the retail ... a new store design to enhance the retail ... food, health-focused products and expanded beauty selections paired ... customers discover new offerings. Together with its innovative ... of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... Miami native ... as a dentist. , “I could have never imagined back in 1991 that this ... said Dr. Gallardo. , Over the last 25 years, Dr. Gallardo has pioneered implant ...
(Date:4/26/2017)... Pa. (PRWEB) , ... April ... ... division, which provides an agile ecosystem and domain expertise for sponsors and ... configurable randomization and trial supply management (RTSM) software platform. Bioclinica AGILE ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... preferred physical therapy provider for Derby City CrossFit, effective immediately. , In addition ... quickly and effectively as possible, ProRehab’s sports physical therapists will work with athletes ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... Liberty attempts to compare student test score performance for the 2015-16 school year ... the state’s voucher programs. Though it highlights important patterns in student test score ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
Breaking Medicine News(10 mins):